Registered entities
ANTHOS THERAPEUTICS, INC.
Reg. No. 83-0933576United States
Innovation
4 patent families — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace steady. Cited 40 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Investor mix
5 investors on record; lead investors include Blackstone, Novartis; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Private equity | 1 | 20% |
| Other / undisclosed | 3 | 60% |